236
Participants
Start Date
September 30, 2006
Primary Completion Date
November 30, 2009
Study Completion Date
January 31, 2011
NovoTTF-100A
multiple four-week courses of continuous NovoTTF-100A treatment
Memorial Sloan Kettering Cancer Center, New York
Weill Cornell Medical College, New York
Columbia University Medical Center, New York
University of Pittsburgh Medical Center (UPMC), Pittsburgh
University Hospital of Schleswig-Holstein, Kiel
University Hospitals of Cleveland, Cleveland
Medical College of Wisconsin, Milwaukee
Evanston Northwestern Healthcare, Evanston
Northwestern University, Chicago
University of Illinois in Chicago, Chicago
Tel Aviv Sourasky Medical Center, Tel Aviv
Boston University Medical Center, Boston
Beth Israel Deaconess Medical Center, Boston
Lahey Clinic Medical Center, Burlington
NJ Neuroscience Institute - JFK Medical Center, Edison
Cleveland Clinic, Cleveland
University of Virginia, Charlottesville
University Hospital Graz, Graz
FN Brno - Masaryk University, Brno
Na Homolce Hospital, Prague
Hospital of Neurology Lyon - University Claude Bernard Lyon 1, Lyon
Group Hospitals Pitie-Salpetriere, Paris
University Hospital Augsburg, Augsburg
University Medical Center Hamburg-Eppendorf, Hamburg
Centre Hospitalier Universitaire Vaudois, Lausanne
NovoCure Ltd.
INDUSTRY